Rachelle Lynn Johns, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6521 Route 22, Delmont, PA 15626 Phone: 724-836-5500 Fax: 724-836-3286 |
Juan Antonio Lora, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6521 Route 22, Delmont, PA 15626 Phone: 724-836-5500 Fax: 724-836-3286 |
News Archive
According to a recent report by USA Today, due to 2010's unusually cold winter temperatures, allergy sufferers are now poised to experience the worst pollen season in years, with pollen counts skyrocketing and sufferers hiding indoors to avoid exposure. Yet as allergens creep indoors, sufferers continue to cough, sneeze and seek relief. With the introduction of EZ Breathe, a new innovative home ventilation system designed to remove allergens and reduce indoor concentrations of pollen, allergy sufferers now have a medication-free solution.
Scientists are reporting development of a fast, simple, inexpensive method for determining whether chemicals in consumer products and workplaces may cause skin allergies in people - a method that does not involve use of animals. Their study appears in ACS' Chemical Research in Toxicology, a monthly journal.
Researchers from Utrecht University have been investigating the interactions between compliance social distance measurements, infection, and vaccination coverage in order to inform public health policy further. A research paper covering their work is available on the medRxiv* preprint server.
Building on previous evidence showing that religious belief involves cognitive activity that can be mapped to specific brain regions, a new study has found that causal, directional connections between these brain networks can be linked to differences in religious thought.
NexBio, Inc. announced today the publication of a "Major Article" in the Journal of Infectious Diseases of a preclinical study showing that treatment with DAS181 (Fludase) inhibits infection with multiple human parainfluenza virus strains. DAS181 is a broad spectrum host-targeted investigational drug candidate for treatment and prevention of Influenza-Like Illness.
› Verified 8 days ago